Products

AI-ECG Platform
Shenzhen Carewell Electronics Co., Ltd.
Cardiology AI
The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
AI-ECG Tracker
Shenzhen Carewell Electronics Co.
Cardiology AI
Shenzhen Carewell Electronics Co., a subsidiary of Lepu Medical, is a pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries.

See all 2 products →

About Shenzhen Carewell Electronics

Shenzhen Carewell Electronics Co., Ltd. (Carewell), a subsidiary of Lepu Medical, is a high-tech enterprise specializing in the research, development, manufacturing, marketing, and after-sale service of advanced medical equipment. The company is recognized as a pioneer in applying artificial intelligence (AI) technology to ECG auto-diagnosis, aiming to enhance the accuracy and efficiency of cardiac diagnoses and expand access to ECG diagnosis in primary medical facilities.

Carewell’s product portfolio includes a wide range of medical devices such as electrocardiographs (ECG machines), multi-parameter patient monitors, ultrasound scanners, infusion and syringe pumps, medical imaging systems, obstetric products, electro-surgical generators, and veterinary products. Their AI-ECG Platform, an AI automatic analysis and diagnosis system for ECG, received clearance from the U.S. Food and Drug Administration (FDA) in November 2018. This AI-ECG Tracker is designed to assist qualified healthcare professionals in hospitals and healthcare facilities with the assessment of arrhythmias using ECG data, by providing automated analysis and interpretation that physicians can review and modify. The company’s analytics system has integrated a vast dataset, including 47 million pieces of data collected from over half a million patients across 2,500 Chinese hospitals. Carewell’s products are distributed to hospitals, clinics, health centers, and medical research institutions in more than 100 countries globally.

Focus Areas

AI ECG auto-diagnosis cardiovascular disease diagnosis arrhythmia detection myocardial infarction detection ventricular hypertrophy detection medical imaging systems multi-parameter patient monitoring deep learning algorithms medical device software

Business Intelligence

Key InvestorsLepu Medical (Parent Company), Intel (Strategic Partner)
PartnershipsIntel (strategic cooperation agreement for AI application in healthcare, 2019)
AcquisitionsJoined Lepu Medical in 2017
TechnologyAI-powered analysis system, deep learning algorithms, neural networks, powerful GPU for AI computing, Intel's AI chips, OpenVINO framework, hardware-independent platform, web-based management portal, Windows-based diagnostic client
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

AI-Powered ECG Auto-Diagnosis
Specializes in rapid and accurate AI-driven interpretation of ECGs, including sophisticated detection of arrhythmias, myocardial infarction, and ventricular hypertrophy. This capability significantly enhances early diagnosis and supports timely clinical intervention.
Comprehensive Cardiovascular Diagnostics
Offers advanced solutions for broad cardiovascular disease diagnosis, leveraging deep learning algorithms to provide deeper insights and support clinical decision-making across a spectrum of cardiac conditions.
Integrated Patient Monitoring & Imaging Systems
Develops multi-parameter patient monitoring systems and medical imaging solutions, potentially integrating AI for enhanced data analysis and diagnostic support across various modalities, offering a holistic view of patient health.
Core Deep Learning & Medical Software Expertise
Built on a foundation of proprietary deep learning algorithms and robust medical device software development, ensuring high reliability, accuracy, and regulatory compliance in their products, which is critical for clinical applications.
Physician Tip

For physicians, Shenzhen Carewell Electronics stands out by offering solutions that promise enhanced diagnostic precision and speed, particularly in complex ECG interpretations. Their AI-driven auto-diagnosis can significantly streamline workflow, reduce interpretation time, and aid in the early and accurate detection of critical cardiovascular conditions like MI and arrhythmias, potentially leading to better patient outcomes. The focus on reliable medical device software also ensures trustworthy and compliant tools for clinical practice. Consider how their integrated monitoring and imaging systems could provide a more comprehensive patient overview and decision support.

While not explicitly detailed, companies specializing in medical device software and AI diagnostics typically design their systems with potential integration into existing hospital information systems (HIS), Electronic Health Records (EHR), and Picture Archiving and Communication Systems (PACS) to facilitate seamless data flow and workflow efficiency within clinical environments.

Products by Shenzhen Carewell Electronics

2 products in the directory

AI-ECG Platform
Shenzhen Carewell Electronics Co., Ltd.
Cardiology AI
The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
AI-ECG Tracker
Shenzhen Carewell Electronics Co.
Cardiology AI
Shenzhen Carewell Electronics Co., a subsidiary of Lepu Medical, is a pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries.

What the Web Says

Shenzhen Carewell Electronics is a small to medium-sized Chinese company specializing in AI-powered medical devices, particularly in cardiology and patient monitoring. They are known for their AI-ECG Platform and AI-ECG Tracker, which have received FDA and EU certifications. The company focuses on producing high-quality, innovative AI medical devices and sells them in over 100 countries. While direct customer and employee reviews are scarce on major platforms like G2, Glassdoor, Capterra, and Reddit, the company is recognized in healthcare IT discussions for its contributions to computational healthcare and AI applications in medicine.

Overall: Positive

Strengths

  • FDA and EU certified products, indicating adherence to international standards.
  • Pioneering in AI-ECG auto-diagnosis.
  • Products designed to improve detection efficiency of arrhythmias.
  • Devices can be used in various healthcare settings, including those lacking specialist doctors.
  • Focus on high-quality, innovative AI medical devices.
  • Global reach with sales in over 100 countries.

Limitations

  • Limited public reviews on major platforms like G2, Glassdoor, Capterra, and Reddit.
  • AI-ECG interpretation results are advisory only and not intended as the sole means of diagnosis.
  • Products are not for use in life-supporting systems or ECG monitoring and alarm devices.
  • Potential challenges with regulatory divergence between China's NMPA and international standards.
  • Supply chain concentration risk with China for medical device components.
  • Vulnerability to raw material cost volatility.

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT reviewers, Reddit, Yicai Global, FDA, IndexBox, PMC, MDPI, FCC Report

Last updated: 2026-07-19

Videos

News, demos, and interviews about Shenzhen Carewell Electronics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Shenzhen Carewell Electronics →

View all on YouTube

Press & Coverage

carewellu51efu6c83u5c14
AI-ECG Platform Gets FDA Clearance
Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical, announced on November 19, 2018, that its AI-ECG Platform, an artificial intelligence automatic analysis and diagnosis system for ECG, received FDA clearance. This marks it as the first Chinese innovative medical device in the AI ECG field to achieve FDA clearance.
2018-11
NAI 500
Lepu Medical Technology's AI-ECG Tracker Gains US FDA's Seal
Lepu Medical Technology Beijing's AI-ECG Tracker, developed by its Shenzhen Carewell Electronics unit, received registration approval from the US FDA on March 24, 2020, following its EU certification last year. The AI-ECG Tracker is intended for qualified healthcare professionals to assess arrhythmias using ECG data from adults.
2020-03
South China Morning Post
Chinese medical device maker's US$2 a day heart attack risk warning system faces resistance in US
Lepu Medical, through its subsidiary Shenzhen Carewell Electronics, developed an AI-powered heart attack risk warning system that gained FDA approval but faces resistance from US healthcare providers. The system, backed by a large patient dataset, offers data analytics at a low cost, potentially disrupting existing income models for doctors.
2019-10
Semantic Scholar
Artificial Intelligence in Translational Medicine
This peer-reviewed article from November 2021 mentions Shenzhen Carewell Electronics, Ltd. and its AI-ECG Platform (K180432) for assisting physicians in ECG interpretation and the AI-ECG Tracker (K200036) for improving the detection efficiency of non-persistent arrhythmias.
2021-11
BMJ Health & Care Informatics
How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices
A peer-reviewed article from April 2021 references Shenzhen Carewell Electronics, Ltd.'s AI-ECG Platform (K180432) as an FDA-approved medical device utilizing machine learning for clinician decision support. The article analyzes how ML devices assist with diagnostic and triage tasks.
2021-04
Frontiers in Cardiovascular Medicine
Artificial intelligence in cardiology: Hope for the future and power for the present
This peer-reviewed article from September 2022 lists Shenzhen Carewell Electronics Co., Ltd.'s AI-ECG Tracker (K200036) as an FDA-approved device for the assessment of arrhythmias using ECG data. It highlights the growing role of AI in cardiology.
2022-09
GLOBAL IP NEWS
Electrocardiogram Monitoring and Analyzing System Patent Application
On July 16, 2026, Shenzhen Carewell Electronics Co Ltd applied for a Chinese patent for an Electrocardiogram Monitoring and Analyzing System. The patent application number is CN202610257758 20260304.
2026-07
FDA
510(k) Premarket Notification K113485
The FDA issued a 510(k) Premarket Notification decision for Shenzhen Carewell Electronics Co., Ltd.'s Electrocardiograph (K113485) on April 25, 2012, determining it to be substantially equivalent to legally marketed predicate devices.
2012-04

Frequently Asked Questions

Shenzhen Carewell Electronics offers the AI-ECG Platform and AI-ECG Tracker, which utilize deep learning algorithms for automatic ECG analysis. These systems are designed to assist qualified healthcare professionals in assessing common cardiac abnormalities, including arrhythmias, myocardial infarction, and ventricular hypertrophy, with reported accuracy exceeding 95% for major cardiovascular diseases.
Carewell's AI-ECG Platform is reported to accurately diagnose arrhythmias, ventricular hypertrophy, and myocardial infarction with an overall accuracy of more than 95%. Their AI-ECG CHECKME product, specifically, boasts 98.3% accuracy driven by a deep learning neural network trained on over 47 million annotated data.
Yes, Shenzhen Carewell Electronics has obtained ISO 13485 and CE certificates, and their ECG products, including the AI-ECG Platform, have received FDA clearance in the United States. They also adhere to EU MDR regulations, demonstrating their commitment to international medical device software compliance.
In addition to their AI ECG solutions, Carewell manufactures ultrasound scanners as part of their medical imaging systems portfolio. They also offer multi-parameter patient monitors, such as the CPM-9000 series, which can measure various physiological parameters including ECG, NIBP, SpO2, RESP, TEMP, PR, and include arrhythmia and ST segment analysis.
While specific details on support tiers are not publicly detailed, Carewell provides general contact information for inquiries and their website lists a 'Support' section. Their AI-ECG Platform includes components like an AI-ECG Workstation for fast computing and a web-based Management Portal for task management and report review, implying a comprehensive system requiring ongoing technical assistance.
Founded in 2002, Shenzhen Carewell Electronics is a national Hi-Tech enterprise with a significant global presence, distributing products to over 100 countries. The company joined LEPU Medical in 2017, a leading Chinese group in cardiovascular interventions, which enhances its stability and technological backing in the advanced AI medical device market.
Carewell's AI-ECG Platform is designed to integrate with compatible resting ECG devices that can export recordings in various formats, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, or MFER ECG. The system provides a professional diagnostic client for physicians to review, modify, and confirm AI-generated interpretations, facilitating integration into clinical workflows.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.